ICLR logo

ICLR

ICON Public Limited CompanyNASDAQHealthcare
$114.19+2.49%OpenMarket Cap: $8.72B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

14.55

PEG

P/B

0.95

P/S

1.08

EV/EBITDA

10.03

DCF Value

$297.53

FCF Yield

11.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

26.9%

Operating Margin

12.2%

Net Margin

7.4%

ROE

6.3%

ROA

14.3%

ROIC

6.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 2025$2.04B$2.4M$0.03
Q2 2025$2.02B$183.0M$2.30
Q1 2025$2.00B$154.2M$1.90
Q4 2024$2.04B$260.0M$3.16

Analyst Ratings

View All
BMO CapitalOutperform
2026-03-26
CitigroupNeutral
2026-03-11
BarclaysEqual Weight
2026-03-09
JefferiesBuy
2026-02-23
TD CowenBuy
2026-02-18

Trading Activity

Insider Trades

View All
Balfe Barry Edwarddirector, officer: Chief Executive Officer
SellWed Mar 18
Balfe Barry Edwarddirector, officer: Chief Executive Officer
SellWed Mar 18
Balfe Barry Edwarddirector, officer: Chief Executive Officer
SellWed Mar 18
Balfe Barry Edwarddirector, officer: Chief Executive Officer
SellWed Mar 18
Balfe Barry Edwarddirector, officer: Chief Executive Officer
SellWed Mar 18

Congress Trades

View All
Julia LetlowSell
Fri Mar 13

Company Info

Sector

Healthcare

Industry

Country

IE

Exchange

NASDAQ

Beta

1.28

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Peers